HEALTH POLICY BRIEF — Friday, May 29

Executive Briefing

- CMS/CMMI transplant model final rule is on public inspection for June 1. CMS is finalizing Performance Year 2 updates to the mandatory Increasing Organ Transplant Access model, effective 30 days after Federal Register publication. Policy relevance: this is a fresh CMMI mandatory-model update affecting participating kidney transplant hospitals, performance scoring, beneficiary notices, and upside/downside risk mechanics. Physician policy angle: specialty practices and transplant programs may care about attribution, patient notice, quality scoring, and payment risk. Source: https://www.federalregister.gov/public-inspection/2026-10890/medicare-program-alternative-payment-model-updates-and-the-increasing-organ-transplant-access-model

- NIST refocused its AI consortium. NIST is retitling the AI Safety Institute Consortium as the NIST Artificial Intelligence Consortium, revising its research scope, and reopening letters of interest on an ongoing basis, with the first review beginning within 60 days of today’s notice. Policy relevance: this is cross-sector AI standards/governance infrastructure, not health-specific, but it may shape federal AI measurement and evaluation frameworks that later influence health AI assurance. Physician policy angle: worth monitoring for physician-led AI governance, clinical validation, privacy, bias, safety, workflow, and accountability use cases. Source: https://www.federalregister.gov/documents/2026/05/29/2026-10779/nist-artificial-intelligence-consortium

- FDA extended comments on its AI-enabled early-phase clinical trials RFI to June 29. The RFI seeks input on a proposed pilot program to assess AI-enabled technologies for improving efficiency, speed, and quality of decision-making in early-phase clinical trials. Policy relevance: this is a concrete HHS/FDA comment opportunity in health AI. Physician policy angle: relevant to clinical evidence standards, trial operations, patient safety, clinician oversight, and how AI-enabled trial tools should be evaluated before broader medical use. Source: https://www.federalregister.gov/documents/2026/05/28/2026-10602/ai-enabled-optimization-of-early-phase-clinical-trials-pilot-program-request-for-information

Federal Health Policy Watch

- CMS/CMMI IOTA final rule: Finalizes selected updates for Performance Year 2, beginning July 1, 2026, and future years of the six-year mandatory model. Notable provisions include excluding VA and military treatment facilities, raising the low-volume eligibility threshold from 11 to 15 kidney transplants in each baseline year, modifying the composite graft survival quality methodology, including Medicare Advantage beneficiaries in upside/downside payment calculations, extending certain extreme-and-uncontrollable-circumstance flexibilities, and adding patient/waitlist transparency requirements. Policy relevance: specialty model implementation and CMMI mandatory-model precedent. Physician policy angle: monitor for how CMS handles specialty-care accountability models, risk adjustment, participant burden, and beneficiary communications.

- OMB government-wide financial assistance proposal: OMB and multiple agencies, including HHS, proposed revisions to 2 CFR federal financial assistance rules, with comments due July 13. Policy relevance: not health-specific, but it could affect HHS grant and cooperative-agreement administration. Physician policy angle: mostly relevant if health IT, public health, AI, standards, or practice-transformation grants face new compliance, oversight, or burden requirements. Source: https://www.federalregister.gov/documents/2026/05/29/2026-10817/regulation-for-federal-financial-assistance

- CMS PRA notice: CMS opened a 30-day OMB review comment period, due June 29, on the Social Security Office Report of State Buy-in Problems collection. Policy relevance is low for this publication’s coverage focus; it is primarily a Medicare/Medicaid eligibility administration collection rather than a physician-practice burden item. Source: https://www.federalregister.gov/documents/2026/05/29/2026-10777/agency-information-collection-activities-submission-for-omb-review-comment-request

Digital Health / AI / Privacy / Cyber / Interoperability

- NIST AI Consortium notice: Monitor as an upstream federal AI standards and measurement forum. The health policy hook is whether health care stakeholders participate early enough to push clinical safety, workflow fit, privacy, bias, and accountability into general-purpose AI evaluation frameworks.

- FDA AI clinical trials RFI extension: Comment window now runs through June 29. Potential comment angles include clinician oversight, validation expectations, transparency of AI-driven trial decisions, data quality, generalizability, patient safety, and how FDA should distinguish operational trial optimization from clinical decision support.

- ONC certified health IT complaint pathway: The X scan surfaced an official ONC reminder about the certified health IT complaint/feedback pathway. Verified background: ONC directs end users with unresolved certified health IT concerns to the Health IT Feedback and Inquiry Portal after working with the developer and ONC-Authorized Certification Body. Policy relevance: this is not a new rule, but it is a useful evidence channel for certification, usability, interoperability, and in-the-field nonconformity issues. Source: https://healthit.gov/certification-health-it/oversight-and-surveillance/

Signal Scan

- X/social scan status: completed with findings. Credible signals included the ONC complaint-pathway reminder, HHS-OIG fraud/enforcement activity, an FTC Medicare-fraud consumer alert, and general health AI implementation-risk commentary. Strategic read: only the ONC reminder is useful for this publication’s core digital health policy work; it reinforces that physician/practice evidence about certified EHR problems should be routed into formal ONC oversight channels where appropriate. No fresh X/social signal changed the prior authorization, HIPAA, information blocking, coding, or standards picture.